Evogene
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,796 | $914 | $4,190 | $578 |
Gross Profit | 715 | -236 | 3,880 | -483 |
EBITDA | -4,681 | -5,229 | -3,008 | -6,965 |
EBIT | -5,308 | -5,842 | -3,679 | -7,628 |
Net Income | -7,630 | -5,419 | -3,863 | -6,601 |
Net Change In Cash | 1,796 | 914 | 4,190 | 578 |
Free Cash Flow | -5,060 | -5,486 | -4,251 | -5,741 |
Cash | 11,317 | 9,484 | 11,915 | 20,772 |
Basic Shares | 5,807 | 5,090 | 5,062 | 5,058 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,640 | $1,675 | $930 | $1,040 |
Gross Profit | 1,399 | 766 | 163 | 466 |
EBITDA | -23,204 | -26,933 | -27,795 | -23,178 |
EBIT | -25,816 | -29,513 | -30,029 | -25,905 |
Net Income | -23,879 | -26,638 | -27,793 | -23,374 |
Net Change In Cash | 5,640 | 1,675 | 930 | 1,040 |
Free Cash Flow | -22,362 | -24,849 | -25,563 | -20,196 |
Cash | 20,772 | 28,980 | 32,325 | 46,229 |
Basic Shares | 4,568 | 4,121 | 4,043 | 2,815 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.06 |
2024-09-30 | -$1.31 |
2024-06-30 | -$1.06 |
2024-03-31 | -$0.08 |
